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The crystal structure of the protected C-terminal dipeptide frag-
ment (Boc-Phe-Pro-NH2) of the µ-opioid receptor highly selective
agonist, morphiceptin (Tyr-Pro-Phe-Pro-NH2), was determined; the
crystals are monoclinic with space group P21 and unit cell dimen-
sions: a = 11.5731(5), b = 6.4490(3), c = 15.4082(5) Å, b = 100.359(5)°
and Z = 2. To examine the influence of proline on the conformation
of peptide bond, the molecular conformation was studied in solid
state and solution (using 1H and 13C NMR data). The X-ray analy-
sis revealed the following conformations of peptide backbone:
f1 = –63.2(5)°, y1 = 156.1(4)°, w1 = –174.3(4)°, f2 = –66.0(5)° and
y2 = 152.0(4)°. The conformation of the Boc group is trans-trans.
Experimental data revealed the trans conformation about the
Phe-Pro amide bond, both in solid state and solution (DMSO). The
possibility of cis/trans isomerization about the peptide bond (w1)
was examined by theoretical calculations using BIOSYM software.
Molecular modelling, including molecular dynamics simulations of
the title dipeptide, is in favour of trans peptide bond.
Key words: C-terminal dipeptide, cis/trans isomerization, morphi-
ceptin, conformational analysis, X-ray structure, NMR, molecular
dynamics simulations.
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INTRODUCTION
Proline plays a unique role in peptide and protein structures having a
capacity to affect local polypeptide environment, where it often participates
in the formation of loops, turns and the polyproline helix.1–3 While most
peptide bonds exist in the trans geometry, those involving proline residue
(Xaa-Pro) display a tendency to assuming both cis and trans conformations
due to the small difference in free energy between these two conformers.3–5
It has been suggested that cis/trans proline isomerization plays many im-
portant biochemical roles, e.g. controlling the rate of protein folding, trigger-
ing receptor-mediated transmembrane signalling, and providing a recogni-
tion element in peptide antigens.6–8 Due to the unique function of proline in
folding and refolding of proteins, cis/trans isomerization has been studied
from various aspects.3,5,9 The recent spectroscopic studies and molecular
mechanics and dynamics calculations on model peptides4,5,10–12 demonstra-
ted that cis/trans equilibria depend on the nature of amino acid residues
flanking the Pro-peptide unit and on the ionization state of terminal groups.
Therefore, the equilibrium should be determined for each Xaa-Pro sequence
individually. MacArthur and Thornton3 performed extensive analysis using
the Protein Data Bank13, which showed strong sequence preferences for cis
versus trans prolines.
Protected C-terminal dipeptide (Boc-Phe-Pro-NH2) is a constitutional
fragment of morphiceptin (Tyr-Pro-Phe-Pro-NH2), one of the most selective
agonists for m-opioid receptor discovered in bovine milk proteins.14,15 Spec-
troscopic studies of morphiceptin revealed the presence of four configura-
tional isomers (trans/trans, cis/trans, trans/cis, and cis/cis) both in water
and dimethyl sulphoxide.16 According to 1H and 13C NMR data, the largest
proportion (amounting to 55%) has been assigned as the all-trans isomer.
The second configurational isomer, accounting for 25%, adopts a cis confor-
mation around the Tyr-Pro amide bond. A topochemical model developed to
explain the bioactivity of morphiceptin suggested the requirement of a cis
amide bond linking N-terminal Tyr-Pro residues.17 In terms of 'bioactive
conformations', the C-terminal address sequence may stabilize a specific
conformation among various conformations accessible to the N-terminal
message sequence and, for full understanding of the opioid activity, it is ne-
cessary to identify the specific conformational states for rotatable bonds
present in this part of the opioid peptide molecule.
This work has focused on the comparative conformational analysis of
Boc-Phe-Pro-NH2, based on X-ray crystallographic studies, NMR spectro-
scopic data and molecular dynamics simulations.
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EXPERIMENTAL
Dipeptide Synthesis
Boc-Phe-Pro-NH2 was synthesized by the conventional liquid-phase method.
Amidation of the Boc-Pro-OH18 was carried out using mixed anhydride activation
followed by treatment with conc. ammonia solution. Boc protection was removed
with 90% TFA and the obtained product was coupled with Boc-Phe-OH by the mixed
anhydride method to yield Boc-Phe-Pro-NH2 in 60% yield; m.p. 326–329 K, aD =
–42.5° (c = 1, MeOH), Lit.19 m.p. 328–331 K.
NMR Experimental Details
NMR spectra were acquired on Varian spectrometers VXR-300, Unity + 300 and
INOVA 600 at 298.15 K. 10 mmol dm–3 solution in DMSO-d6 was used. Chemical
shifts are reported in ppm relative to tetramethylsilane as internal standard. Data
were processed using Varian VNMR software. COSY, NOESY and ROESY were ac-
quired with 512 increments and 8 (at 600 MHz) or 32 (at 300 MHz) transients. For
NOESY and ROESY experiments, mixing times of either 250 or 500 ms with different
transmitter offsets were used. Heteronuclear multiple-quantum coherence (HMQC
with 512 increments and 32 transients) experiments were used for the detection of
13C–1H correlations. 1D 13C NMR spectrum was acquired at 75.4 MHz with 103000
transients.
X-ray Structure Determination
The peptide was crystallized from the solvent mixture ethanol/diisopropyl ether
(1 : 1 v/v) by slow evaporation at room temperature for 1 day. The crystal data and
details of data collection and refinement are listed in Table I. The X-ray intensity
data were collected with an Enraf-Nonius CAD4 diffractometer with graphite-
monochromatized Cu-Ka radiation. There were no significant variations in intensity
for standard reflections. The data were corrected for Lorentz and polarization ef-
fects.20 The structure was determined by direct methods using the SHELX86 pro-
gram.21 Refinement was performed by full-matrix least-squares with the SHELX9322
system of programs on F2 values. Most hydrogen atoms were calculated on stereo-
chemical grounds and refined riding on their respective C atoms. Atomic scattering
factors were those included in SHELX93.22 Details of the refinement procedure are
given in Table I. During structure determination, the enantiomer with the absolute
configuration S on C1
 and C2
 according to the synthesis procedure, was selected. The
solvent molecule (ethanol) was located in a Fourier map. The molecular geometry
was calculated by the EUCLID program.23 Drawings were prepared by the PLUTON
program incorporated in EUCLID23 and ORTEP II.24 The final atomic coordinates
and equivalent isotropic thermal parameters are listed in Table II.
Molecular Mechanics and Molecular Dynamics Simulations
In order to examine the possibility of cis/trans imide isomerization of N-tert-butyl-
oxycarbonyl-L-phenylalanyl-L-proline amide and to compare the conformations in solid
state and solution, molecular mechanics and dynamics calculations were carried out
using DISCOVER25 (BIOSYM, ver. 2.9.7 & 95.0 / 3.00, 1995) with the AMBER26 force
field.
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TABLE I
General and crystal data and details of the diffraction procedure and structure
determination
Crystal data
Empirical formula C19N3O4H27  C2H6O
Molecular weight, Mr 407.51
a / Å 11.5731(5)
b / Å 6.4490(3)
c / Å 15.4082(5)
b / ° 100.359(5)
V / Å3 1131.25(8)
Unit cell contents, Z 2




Crystal size / mm 0.11  0.07  0.34
m (Cu-Ka) / cm–1 6.98
Data collection
Diffractometer Enraf-Nonius CAD4
Radiation / Å l(Cu-Ka) = 1.54184
graphite monochromator
Temperature / K 295(3)
qmin , qmax / ° for cell det. 12, 47
No. of reflections used for cell det. 25
qmin , qmax / ° 2.92, 74.36
(w/2q scan) / ° w = 0.62 + 0.26 tanq
h, k, l limits 0, 14; 0, 8; –19, 19
Refinement
Independent reflections observed with I > 4s(I) 1736
No. of parameters 309
Refinement on F2
w = 1 / s2(Fo2) + (0.1037 . P)2, P = (Fo2 + 2Fc2) / 3
R(F), wR(F2) 0.053, 0.156
Goodness of fit, S 0.974
Max. shift / error (  s)max < 0.05
Residual electron density,
rmax, rmin / e Å–3 0.26, –0.22
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TABLE II
Final atomic coordinates and equivalent isotropic thermal parameters of the
nonhydrogen atoms with estimated standard deviations given in parentheses
Atom x y z Ueq / Å2
O 0.8987(2) 0.2419(7) 0.2082(1) 0.051(1)
O1 0.5714(2) 0.1860(7) 0.1167(1) 0.0505(9)
O2 0.2874(3) 0.1576(8) 0.0847(2) 0.066(1)
O0 0.8151(3) –0.0773 0.1935(2) 0.051(1)
N1 0.7403(2) 0.1860(7) 0.2645(1) 0.0407(9)
N2 0.4802(3) –0.0906(7) 0.1593(1) 0.0406(9)
N3 0.3106(3) 0.062(1) –0.0522(2) 0.062(1)
C1 0.9650(5) 0.116(1) 0.0753(3) 0.082(2)
C1' 0.5583(3) 0.0618(8) 0.1737(2) 0.035(1)
C2 1.0622(5) 0.400(1) 0.1674(4) 0.077(2)
C2' 0.3309(3) 0.0465(9) 0.0359(2) 0.044(1)
C3 1.0785(5) 0.039(2) 0.2264(4) 0.097(3)
C4 1.0028(3) 0.188(1) 0.1679(2) 0.049(1)
C5 0.8187(3) 0.0995(8) 0.2194(2) 0.039(1)
C
 0.6315(3) 0.0791(8) 0.2675(2) 0.034(1)
C
	 0.5611(3) 0.1950(9) 0.3289(2) 0.044(1)
C

 0.6173(3) 0.1820(9) 0.4249(2) 0.044(1)
C
 0.6755(5) 0.349(1) 0.4675(3) 0.067(2)
C
 0.7283(6) 0.336(2) 0.5551(3) 0.091(3)
C 0.7220(5) 0.157(2) 0.6014(3) 0.089(3)
C
 0.6627(6) –0.011(2) 0.5608(3) 0.090(3)
C
1 0.6097(5) 0.001(1) 0.4720(3) 0.068(2)
C
 0.4145(3) –0.1313(8) 0.0705(2) 0.043(1)
C
	 0.3469(6) –0.329(1) 0.0803(3) 0.085(2)
C

 0.3765(6) –0.394(1) 0.1688(3) 0.092(2)
C
 0.4585(4) –0.2521(9) 0.2211(2) 0.060(2)
O6a 0.2112(3) 0.1166(7) 0.6865(2) 0.058(1)
C6a 0.0995(5) 0.105(1) 0.6294(3) 0.077(2)
C7a 0.0790(7) 0.280(2) 0.5673(4) 0.110(3)
a Ethanol.
b Ueq = (1 / 3) ijUij ai*aj*ai.aj.
The following torsion angles of the peptide backbone were chosen for conforma-
tional search: w0, f1, y1, w1, f2 and y2 (Scheme 1). The structural flexibility of the Phe
was examined by inspection of its side chain torsion angles 1
1 and 1
2.
Energy optimization of the crystallographically determined structure was per-
formed in vacuo without constraint. The results are summarized in Table III. In or-
der to examine the possibility of cis-proline orientation, simultaneous rotations







 (w1) in 24 steps (15°
each) were calculated. To simulate the conditions of NMR measurements, molecular
dynamics simulations were performed in DMSO with AMBER26 force field using pe-
riodic boundary conditions. The explicit image model applying two values of the cut-
off parameters (14 and 15 Å) was used with a cube (a = 32 Å) as a unit cell. The dis-
tance dependent dielectric constant was chosen during the molecular dynamics cal-
culations. The sterically relaxed X-ray structure was soaked in the DMSO box47
filled with about 210 molecules of DMSO. At the beginning, the entire system was
subjected to minimization that included a combination of steepest descent and con-
jugate gradient method and in the final stage the BFGS (Broydon-Fletcher-Gold-
farb-Shanno)25 algorithm (gradient norm < 10–3 kcal / mol Å). After 5 ps of equilibra-
tion, the simulation over 320 ps was carried out at 300 K. To sample the larger
conformational space, the simulation over 320 ps was also performed at elevated
temperatures (300 K, 350 K, 400 K over 50 ps each, 450 K over 100 ps and again 300
K over 70 ps). In order to compare the influence of solvent on the conformational
flexibility with respect to molecular dynamics calculations performed in DMSO, mo-
lecular dynamics simulations were also performed in vacuo.
RESULTS AND DISCUSSION
NMR Studies, Molecular Conformation in Solution
1H and 13C resonances were assigned using 1D and 2D experiments
mentioned in the Experimental section. Experimental data were compared
with those obtained for Boc-Phe-OH, H-Pro-NH2 as well as with proton
264 B. KOJI]-PRODI] ET AL.
Scheme 1. Torsion angle assignments used in the conformational analysis.


































































































































































































































































































































chemical shifts of random-coil peptides.27 The diastereotopic b protons of
Phe were assigned via aH–bH couplings and NOEs with Pro-C2
 protons.
Chemical shifts and coupling constants are given in Tables IV and V. Al-
though cis and trans conformations across the X-Pro amide bond are often
similar in energy, and their interconversion is slow on the NMR time
scale,5,10–12,16 only one set of resonances in 13C NMR spectrum was observed
for dipeptide Boc-Phe-Pro-NH2, suggesting the presence of one isomer in
DMSO-d6 solution (Figure 1). On the basis of
13C chemical shift resonances
of the proline ring carbons, reflecting the configuration about X-Pro amide
bond,28 Phe-Pro bond in trans conformation was found in solution. This as-
sumption was borne out by the small 13C chemical shift difference, d = 4.66
ppm, observed between Pro-C2
	 and Pro-C2

 carbons (Table IV) characteristic
of trans amide linkages, while larger differences (d = 8–10 ppm) are indica-
tive of cis-proline linkages.28 This is also supported by: a) large downfield
shifts of proton resonances of Phe-C1
 and Pro-C2
 (4.34 ppm and 4.24 ppm,
respectively), which are very sensitive to cis  trans isomerization due to
the influence of the anisotropic proline carbonyl group;12,16,29–32 b) splitting
of Phe-C1
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TABLE IV


































The relative populations of staggered conformations about Phe-C1
–Phe-
C1
	 bond, characterized by torsional angle 1
1
,




	 ' coupling constants. The calculated conformation defines the
following rotamers: 1
1 = –60°, predominant (populated 69%), 1
1 = 60°, (po-
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Figure 1. 13C NMR spectrum of Boc-Phe-Pro-NH2 in DMSO-d6.
TABLE V
Experimental values of coupling constants 3J for the conformation detected in
solution (DMSO-d6) and derived from the solid state (X-ray structure) and
calculated values from molecular dynamics simulations
Residue Coupling constants / Hz Refs.
Experimental Calculated
NMR X-ray Molecular dynamics
simulations
Phe-N1–Phe-C1
 8.4 3.14 8  3 42
Phe-C1
–Phe-C1
	 3.6 0.4 2  1 43
Phe-C1
–Phe-C1
'	 10.2 8.7 8.7  0.8 43
Pro-C2
–Pro-C2
	 3.6 2.7 1.2  0.6 44
Pro-C2
–Pro-C2
	' 8.4 8.2 7  2 43
Calculations of coupling constants were performed for each time step of the trajectory and
subsequently averaged45 whereas the equations are used as given in Refs. 42–44.
pulated 23%) and 1
1 = 180°, (populated 8%). For the rotamer with 1
1 = –60°,
the orientation of C1
 / C1
	 proR protons is trans and this finding is in agree-
ment with much stronger NOE between Pro-C2
 and Phe-C1
	 proS protons than
that between Pro-C2
 and Phe-C1
	 proR protons which are further apart.
The analysis of NMR data shows that Boc-Phe-Pro-NH2 prefers trans
orientation (w1) in DMSO-d6 solution, which together with the dominating
rotamer (1
1 = –60°) about the C1
–C1
	 bond indicate the high conformational
constraints in this part of the molecule.
X-ray Analysis
Molecular Structure
The ORTEP drawing24 with thermal ellipsoids scaled at 30% probability
level and atom numbering35 is shown in Figure 2. It includes a molecule of
solvent – ethanol. Selected bond lengths and angles are listed in Table VI.
In the crystal structure studied, the peptide bond is planar: the mean value
of deviation from planarity is 0.009(15) Å. Pyrrolidine ring is also planar
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Figure 2. Molecular structure (ORTEP drawing) with atom numbering. Thermal el-
lipsoids are scaled at 30% probability level. Atom labeling is according to Ref. 35.
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TABLE VI
Interatomic bond distances and valence bond angles with estimated standard
deviations given in parentheses
Bond lengths / Å Bond angles / °























C1–C4 1.490(6) O–C4–C1 110.5(3)
C1'–C1
 1.542(4) O–C4–C2 101.1(5)
C2–C4 1.53(1) O–C4–C3 109.2(3)
C2'–C2
 1.533(7) C1–C4–C2 109.3(5)
C3–C4 1.491(9) C1–C4–C3 114.6(6)
C1
–C1




 1.507(4) O–C5–O0 126.2(4)
C2
–C2























































in phenyl ring <120.0(7)>
a Ethanol.
within the limits of experimental errors: the mean torsion angle value is
0.7(6)° (Table VII). The mean value of atom displacement from the best
least-squares plane defined by pyrrolidine ring is 0.004(16) Å. The planarity
of the pyrrolidine ring is also illustrated by the torsion angles  2
1 –1.1(6)°
and  2
2 0.8(8)°. According to the literature,36,37 puckered conformations of
pyrrolidine rings of proline were detected. For trans conformation of L-pro-
line in a peptide backbone, the pyrrolidine puckering of Cg-endo and Cg-exo
were observed with a preference of Cg-endo.37,38 However, proline in the cis
conformation exhibits a pyrrolidine ring in the Cg-exo conformation only. In
the title dipeptide, proline is a C-terminal amino acid with almost planar
pyrrolidine ring.
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TABLE VII
Selected torsion angles / °


























































































Dipeptide Conformation in Solid State
The overall molecular conformation is described by selected torsion an-
gles listed in Table VII. The conformation of the Boc-group defined by the
torsion angles w0 166.1(3)° and q0 174.4(2)° is trans-trans, as observed in
other Boc-protected peptides.39 The hydrogen bonds between ethanol and
N-tert-butyloxycarbonyl group contribute to the trans-trans conformation of
the Boc-group. The characteristic torsion angles for peptide backbone con-
formation are: f1 = –63.2(5)°, y1 = 156.1(4)°, w1 = –174.3(4)°, f2 = –66.0(5)°,
and y2 = 152.0(4)° (Scheme 1 and Table VII). According to the values of f
and y, trans proline residue is of b type which is generally characterized by
f » –65° and y » 150°.3 The extensive analysis of cis/trans isomerization and
the proline conformations in proteins5,9,40 revealed that the conformation
adopted by the proline is influenced by the nature of the preceding residue.
The recent analysis of MacArthur and Thornton,3 based on non-homologous
protein structures determined at  2.5 Å resolution, including 963 non-
identical trans proline residues, showed that both a and b types are present
in Phe-Pro sequence (51 : 49).
The conformation of the Phe side chain is described by 1
1 and 1
2 (Table
VII). The angle of 63.4(3)° between bond C1
–C1
	 and an aromatic system de-
fines its orientation towards a peptide backbone (Figure 2). The angle be-
tween the best least-squares planes of phenyl and pyrrolidine ring is 13.5°.
Crystal Packing
The crystal packing is illustrated in Figure 3. Two-dimensional network
is realized via hydrogen bonds of N–HO and O–HO types (Table VIII).
The solvent molecule (ethanol) participates as a donor and an acceptor in
hydrogen bonds to the peptide molecule via O6–HO0 and N1–HO6 (Fig-
ure 3, Table VIII). Molecules related by the symmetry operation of 21 are
connected by hydrogen bonds N3–H331O0 and N3–H332O1 into helices
along b, which include the eleven-membered ring structure R 4
3 (11) as des-
cribed in the graph set notation.41
Comparative Conformational Analysis
The analysis includes comparison of the molecular conformations in so-
lid state (X-ray data) and in DMSO-d6 solution (NMR data) with the results
of molecular mechanics and molecular dynamics simulations performed in
DMSO (Table V).
The most interesting part of the conformational analysis is related to the
peptide backbone, particularly the orientation of the proline residue (w1). In
the solid state, the trans proline conformation w1 = –174.3(4)° is observed.
Sterical reasons related to the formation of hydrogen bonds between the
DIPEPTIDE FRAGMENT OF MORPHICEPTIN 271
amide protons and neighbouring molecules N3–H331
 O0, 3.335(6) Å and
N3–H332
O1, 3.038(7) Å (Figure 3, Table VIII) are in favour of the trans
proline orientation. An analogous example in the literature46 is the crystal
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Figure 3. Crystal packing dominated by hydrogen bonds. Molecules of solvent (etha-
nol) are shaded. Hydrogen bonds are shown by dashed lines.
TABLE VIII
Hydrogen bond geometry with estimated standard deviations given in parentheses
Type of
H-bonds
D    A / Å D–H / Å H    A / Å D–H    A / ° Symmetry
operations on A
N1–H1    O6a 2.906(6) 0.860(6) 2.077(6) 162(1) x, y, z
O6a–H6a    O0 2.759(4) 1.01(6) 1.77(6) 168(4) x, y+1, z
N3–H331    O0 3.335(6) 0.99(9) 2.44(8) 150(5) 1–x, 1 / 2+y, –z
N3–H332    O1 3.038(7) 1.07(7) 2.02(7) 157(5) 1–x, 1 / 2+y–1, –z
a Ethanol.
D: donor, A: acceptor
structure of Boc-Pro-Phe-Pro-OH with intermolecular hydrogen bonds be-
tween carbonyl oxygen of the C-terminal Pro and the amide proton of the
Phe for both conformers (in the unit cell) with the trans proline orientation.
The bulky, protected Boc-group restricts free rotation of the phenyl ring
(Phe residue) and thus limits the conformational space for trans/cis conver-
sion.
Experimental evidence from NMR data for the title dipeptide strongly
confirms the trans Phe-Pro amide bond orientation (w1  180 °) and this
finding is supported by the results extracted from molecular mechanics and
molecular dynamics simulations. The simultaneous rotations about two
bonds C1'–N2 (w1) and C1
–C1
	 (1
1 ) revealed energy minimum for w1  180 °
and three energetically distinct rotamers with 1
1 = –60 °, + 60 ° and 180 °
(Figure 4a). Molecular dynamics simulations confirmed that 1
1 = –60 ° and
1
1 = + 60 ° are dominant rotamers, as it was experimentally deduced from
NMR coupling constants (Table V). For the highly populated rotamer (1
1 =
–60 °), the close contacts between Phe-C1
	 proS and Pro-C2
 protons (Figure 4b)
are only possible for the trans positioned Pro accompanied by the corre-
sponding NOE. In solid state, the rotamer 1
1 = –69.5 ° was observed as
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Figure 4. a) Molecular dynamic simulations performed over 320 ps at elevated tem-
peratures (300 K, 350 K, 400 K over 50 ps each, 450 K over 100 ps and again 300 K
over 70 ps) in DMSO. The values of torsion angles w1 and 1
1 obtained during the
simulations are superimposed on the contour graph (obtained by rotations about the
same torsion angles). Contour lines are drawn at an interval of 8.37 kJ / mol. Lo-
cations of energy minima in contour graph coincide with the mostly populated con-
formations in molecular dynamics simulation (high density dots).
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Figure 4. b) Molecular dynamics simulations performed over 320 ps at room tem-
perature (300 K) in DMSO. Variations of the distance between Phe-C1
	proS and Pro-C2

protons during the simulation time are shown. The corresponding NOE was obser-
ved in NMR experiments.
Figure 4. c) Molecular dynamics simulations performed over 320 ps at room tem-
peratures (300 K) in DMSO.Variations of the distance between Phe-C1
 and Pro-C2

protons during the simulation time are shown. The corresponding NOE was ob-
served in NMR experiments.
well. Molecular dynamics simulations performed even at higher tempera-
tures revealed the trans proline orientation, only. The strong NOE between
Phe-C1
 and Pro-C2
 protons (Figure 4c) corresponds to the trans Pro orienta-
tion.
In order to examine the influence of a Boc-group on the trans/cis transi-
tion molecular dynamics simulations at 800 K of H-Phe-Pro-NH2 was per-
formed in vacuo. After 200 ps the trans/cis transition occurred with a two
times lower barrier than in Boc-Phe-Pro-NH2. It is important to mention
that NMR data of unprotected H-Phe-Pro-NH2 also detected both isomers in
70 : 30 ratio (in favour of trans).19
Supplementary Materials. – Crystallographic data for the structure reported in
this paper have been deposited at Cambridge Crystallographic Data Centre, 12
Union Road, Cambridge CB2 IEZ, UK (fax: + 44–1223–336033; e–mail: deposit@
ccdc.cam.ac.uk) and can be obtained on request, free of charge, by quoting the
publication citation and the deposition number 102928.
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Konformacijske studije u ~vrstom stanju i otopini C-za{ti}enog
dipeptidnog dijela (Boc-Phe-Pro-NH2) morficeptina
Biserka Koji}-Prodi}, Snje`ana Antoli}, Marina Kveder, Ivanka @igrovi},
Jurka Kidri~ i [tefica Horvat
Odre|ena je kristalna struktura C-za{ti}enog dipeptidnog dijela (Boc-Phe-Pro-
NH2) visoko selektivnog antagonista m-opioidnog receptora morficeptina (Tyr-Pro-
Phe-Pro-NH2); kristali su monoklinski, prostorne skupine P21 i dimenzija jedini~ne
}elije: a = 11,5731(5), b = 6,4490(3), c = 15,4082(5) Å, b = 100,359(5) ° i Z = 2. Prou~avana
je molekulska konformacija u ~vrstom stanju i otopini (uporabom 1H and 13C NMR
podataka), da bi se ispitao utjecaj prolina na konformaciju peptidne veze. Rentgenska
analiza pokazala je sljede}u konformaciju peptidne veze: f1 = –63,2(5) °, y1 = 156,1(4) °,
w1 = –174,3(4) °, f2 = –66,0(5) ° i y2 = 152,0(4) °. Konformacija Boc-skupine je trans-
trans. Eksperimentalni podatci pokazuju trans konformaciju oko amidne veze Phe-Pro
u ~vrstom stanju kao i u otopini (DMSO). Mogu}nost cis/trans izomerizacije oko pep-
tidne veze (w1) istra`ena je teorijskim metodama uporabom programskog paketa
BIOSYM. Molekulsko modeliranje, uklju~uju}i simulaciju molekulske dinamike na-
slovnog peptida, tako|er potvr|uje trans-peptidnu vezu.
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